Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 ABL Supports Fill/Finish of COVID-19 Vaccine Candidate | Contract Pharma

What are you searching for?

Sign in
Breaking News

ABL Supports Fill/Finish of COVID-19 Vaccine Candidate

Utilizes its aseptic fill/finish facility to support clients' COVID-19 vaccine development

By: Contract Pharma

Contract Pharma Staff

Advanced BioScience Laboratories, Inc. (ABL), a global contract development and manufacturing organization (CDMO) and contract research organization (CRO) for biotherapeutics, oncolytics and vaccines has completed the aseptic fill/finish of a novel COVID-19 vaccine candidate for a confidential customer.
 
ABL said it readied the fill/finish line within a week to vial the vaccine for upcoming clinical trials.
 
In addition to this completed effort, ABL said it is in negotiations with multiple industry and U.S. government clients to apply its capabilities to support COVID-19 vaccine and therapeutic product development. 
 
“We are in active discussions with a number of clients to support the manufacture and testing of COVID-19 vaccine candidates,” said Jarlath Keating, chief executive officer, ABL. “We understand the need to be flexible and responsive in order to best support the rapid development programs our clients have established in the fight against the spread of COVID-19.  ABL’s global GMP operations are in place to meet the increased capacity requirements, while still maintaining strict compliance with regulatory authorities.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics